atopic dermatitis

Manuka honey tested as AD treatmentA pilot study shows that Manuka honey may have some healing properties in atopic dermatitis.
An AD treatment phobia that is a “phenomenon”Atopic dermatitis patients have a phobia of topical corticosteroids that is so strong, it’s been described as a “phenomenon.”
Atopic dermatitis phenotypes may indicate outcomes
Atopic dermatitis phenotypes may indicate outcomesChildren under two years old with signs of atopic dermatitis have an increased risk of developing asthma and food allergies, researchers report in JAMA Pediatrics. And, young children with both early onset atopic dermatitis and a food allergy, have a “very high risk” of developing asthma or allergic rhinitis.
Patch testing remains underreported
Patch testing remains underreportedPatch testing for allergic contact dermatitis in the pediatric population is performed at a higher rate than previously reported, but still grossly underreported, according to a study of the Pediatric Contact Dermatitis Registry.
Treatment updates for atopic dermatitis in childrenBecause the burden of atopic dermatitis in children is significant and can adversely impact a child’s normal socialization development, accurate diagnosis and effective treatment are vital.
Oral baricitinib instead of topicals for atopic dermatitis?EADV study shows that this JAK inhibitor is a promising drug candidate in moderate-to-severe AD.
Atopic dermatitis associated with different bacteria depending on disease severityNIH investigators find that Staphylococcus epidermidis is predominant in less severe cases, while Staphylococcus aureus is associated with patients who have more severe disease.
Ingredients in eczema topicals pose contact dermatitis riskIngredients used in topical products used to relieve atopic dermatitis in children might put those patients at higher risk for contact dermatitis.
Asthma and food allergies associated with early-onset ADChildren with early-onset atopic dermatitis (AD) have an increased risk of developing asthma and food allergies by age 6 years, especially those with persistent dermatitis symptoms.
Psoriasis and atopic dermatitis respond to IL-17 creamNitric oxide-releasing cream that targets IL-17 moving toward clinical trials.